about
The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cellsEphA2 is an essential mediator of UV radiation-induced apoptosisIdentification of cells initiating human melanomasExpression analysis of secreted and cell surface genes of five transformed human cell lines and derivative xenograft tumors.Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumorsStem cells and targeted approaches to melanoma cureMetastatic cancer stem cells: from the concept to therapeuticsMelanoma: from mutations to medicineCell-of-Origin of Cancer versus Cancer Stem Cells: Assays and InterpretationsData-derived modeling characterizes plasticity of MAPK signaling in melanomaAcquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3KLoss of Endocan tumorigenic properties after alternative splicing of exon 2.Skeletal muscle phenotypically converts and selectively inhibits metastatic cells in miceInhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway.Expression of the embryonic stem cell transcription factor SOX2 in human skin: relevance to melanocyte and merkel cell biologyHMGA2 promotes vasculogenic mimicry and tumor aggressiveness by upregulating Twist1 in gastric carcinomaRegulation of cancer aggressive features in melanoma cells by microRNAs.Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis.Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications.Diversity in TAF proteomics: consequences for cellular differentiation and migration.Emerging strategies for EphA2 receptor targeting for cancer therapeutics.Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study.Nicotinamide inhibits vasculogenic mimicry, an alternative vascularization pathway observed in highly aggressive melanomaMicrotubule-associated protein 2, a marker of neuronal differentiation, induces mitotic defects, inhibits growth of melanoma cells, and predicts metastatic potential of cutaneous melanomaEphA2 is a critical oncogene in melanoma.Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanomaEph receptors and ephrins as targets for cancer therapy.Induction of Vasculogenic Mimicry Overrides VEGF-A Silencing and Enriches Stem-like Cancer Cells in MelanomaThe non glycanated endocan polypeptide slows tumor growth by inducing stromal inflammatory reaction.Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications.Claudin-4 is required for vasculogenic mimicry formation in human breast cancer cells.Understanding cancer stem cell heterogeneity and plasticity.Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.Short-term anti-vascular endothelial growth factor treatment elicits vasculogenic mimicry formation of tumors to accelerate metastasis.Biomimetic hydrogels with immobilized ephrinA1 for therapeutic angiogenesisVasculogenic mimicry is a major feature and novel predictor of poor prognosis in patients with orbital rhabdomyosarcoma.Deltex-3-like (DTX3L) stimulates metastasis of melanoma through FAK/PI3K/AKT but not MEK/ERK pathway.Eph/ephrin signaling in epidermal differentiation and diseasePotential for cripto-1 in defining stem cell-like characteristics in human malignant melanoma.Thalidomide influences growth and vasculogenic mimicry channel formation in melanoma.
P2860
Q21093314-E626D578-0316-449C-8DD6-3F430416E0DEQ24311103-AD102C7C-CBDE-4DCD-96E9-222FB16C1F6FQ24622896-FA47CDF3-702A-495D-9737-96C06F0F1DC4Q24803501-1D556E41-C8E3-4DAD-927D-0C5F8FF4ED3AQ26749164-77CFF292-745E-471E-B50A-35D3DCE6755FQ26825014-BC82C684-26C1-4D6F-BB41-586937D9C4EFQ26850739-37161224-458E-411A-AB4E-458482F01F8BQ27024061-4E7D5784-F1E5-40E1-8C59-56A460F26CA3Q28080701-13AA0019-AD82-4890-8D4B-970F4D4E2E00Q28542760-F9C5621C-52C7-4427-9263-D0A43D61615AQ29614757-48CA82AC-45E2-42B0-A3CD-4FD53F1DC5CDQ33315465-AEBA9B4A-4211-45FC-9F1B-72EDE5F34AA2Q33533313-117E5868-68EE-4D96-95DC-920E8FC5005EQ33584252-04AF1249-9136-458D-8CA9-5A1FC441E44FQ33597213-9C0EB847-2C0B-4140-A29D-DFCC9D1CFFDEQ33714914-1628B927-9C57-4EC7-912F-833D7A8AADB6Q33889489-D039F8B5-3DB6-4ACE-A0C3-8A4B8718776AQ34031959-17381424-1B17-4EA1-B50A-11F706C04B77Q34265783-B81755BB-BA83-4E28-9214-0D07CA700C12Q34358974-755C0DDA-A4DA-4C79-BA1A-B7EA77091282Q34469271-60929B3E-2DD8-4C3A-B8D1-16FAE66C175BQ34482255-A2D3D7A4-AF88-4FFD-AB92-CC8B3E812374Q34603154-7C1B8258-9908-439C-A2FD-DD95688DBA86Q35083873-7982474A-63A4-4D63-BF49-9787E3DAC9F7Q35218960-C0BAF485-BE8A-45A5-8C07-EBFEE4F68A92Q35229597-8DFAAEBC-0A3E-4A67-A421-77EA93A1B11EQ35370195-83BE3BCA-58CB-4B53-A451-E86C75E48F8BQ35463820-1CD204EF-8E8A-4CBE-9E34-1FE5D1039B2AQ35550081-E0A4B881-D658-4136-B95A-729407052A22Q35570450-B924311B-56CB-4E8E-A6C1-6266D14361B9Q35793725-E3B3EF07-E3C4-4424-ACA0-384170144442Q35796886-4CF04C88-6485-479F-BF6D-4B75899F9FD1Q35809642-30324850-5842-417E-AE34-51CB774402D0Q35848075-E8FF4585-1914-4F6C-AD9F-C6438FF5744AQ35896879-A1936D5D-9D46-4D69-A3DC-D82FA610865CQ35943307-7F5A1DB7-A55D-4143-949B-C64D40614BEAQ35987334-B02F39A1-2DC6-40D7-A273-36AC513194A1Q36045304-E29C4161-5ADC-4446-9C30-BE4C20D9997DQ36916654-CA6566E5-9589-4E4B-BACF-DD61794A9967Q36999563-7C5484CF-4CD2-4581-968A-D7D944FFDBBC
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Molecular plasticity of human melanoma cells.
@ast
Molecular plasticity of human melanoma cells.
@en
type
label
Molecular plasticity of human melanoma cells.
@ast
Molecular plasticity of human melanoma cells.
@en
prefLabel
Molecular plasticity of human melanoma cells.
@ast
Molecular plasticity of human melanoma cells.
@en
P2093
P2860
P356
P1433
P1476
Molecular plasticity of human melanoma cells.
@en
P2093
Angela R Hess
Elisabeth A Seftor
Mary J C Hendrix
Richard E B Seftor
P2860
P2888
P304
P356
10.1038/SJ.ONC.1206447
P407
P577
2003-05-01T00:00:00Z